Supply Chain Coordinator – BeNeLux Region at Acadia Pharmaceuticals

Lisbon, Lisbon, Portugal

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Bachelor’s degree in Supply Chain, Logistics, or related field
Minimum 5 years of experience in warehouse or supply chain coordination within a regulated (GxP) environment (pharma preferred)
Strong knowledge of logistics operations, inventory systems, and transportation management
Excellent communication and organizational skills
Fluent in Dutch and English (written and spoken); French is a strong plus
Strong IT skills, with hands-on experience in SAP S4/Hana, MS Office Suite, and PowerBI

Responsibilities

Coordinate inbound shipments, ensuring timely receipt, accurate documentation, and customs compliance
Oversee warehousing operations (3/4PL in the Netherlands) with full GxP compliance and SOP adherence
Manage outbound logistics to customers and distributors, resolving delivery issues when needed
Maintain accurate inventory records, monitor stock levels, and address discrepancies
Handle product returns (damaged, expired, or recalled) in collaboration with Quality and Regulatory teams
Act as the main contact for 3/4PL partners, monitoring KPIs, costs, and service levels while driving improvements
Lead monthly business reviews and coordinate transportation planning across the region

Skills

Supply Chain Coordination

Logistics

Warehousing

Inventory Management

GxP Compliance

Customs Compliance

SOP Adherence

KPI Monitoring

3PL Management

4PL Management

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free